Sodium-Glucose Co-Transporter-2 Inhibitors SGLT-2 inhibitors, such as dapagliflozin, empagliflozin, and canagliflozin, are a new class of anti-diabetes drugs that block glucose reabsorption from the renal tubules
Most physicians recommend baseline testing before starting semaglutide, then follow-up labs every 36 months during the first year
Keep reading Published on: February 10, 2021 Well Starts with Healthy Hearts Its impossible to count all the ways your heart supports you in a single day
*The anti-obesity drugs' estimated percentile ranking of weight loss of 10% in participants who took weight-loss medications for more than a year is Phentermine-Topiramate, 54%
By supporting both the activation of metabolic hormones and the structural health of your gut microbiome, the LifeVantage MindBody GLP-1 System offers a comprehensive, clinically backed, non-synthetic alternative to help you achieve your long-term weight management goals.